VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer

Slični predmeti

• Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control
  od: Wajja, A, i dr.
  Izdano: (2024)
• Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
  od: Zhang, C, i dr.
  Izdano: (2023)
• Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV
  od: Charlotte Davis, i dr.
  Izdano: (2024-06-01)
• Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
  od: Cheng Zhang, i dr.
  Izdano: (2023-06-01)
• Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
  od: Adam Berg, i dr.
  Izdano: (2021-10-01)